These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 2806372

  • 1. Direct labeling of rat M3-muscarinic receptors by [3H]4DAMP.
    Michel AD, Stefanich E, Whiting RL.
    Eur J Pharmacol; 1989 Aug 03; 166(3):459-66. PubMed ID: 2806372
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
    Delmendo RE, Michel AD, Whiting RL.
    Br J Pharmacol; 1989 Feb 03; 96(2):457-64. PubMed ID: 2924085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Binding characteristics of the muscarinic receptor subtype of the NG108-15 cell line.
    Michel AD, Delmendo R, Stefanich E, Whiting RL.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul 03; 340(1):62-7. PubMed ID: 2797216
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec 03; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 11. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug 03; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 12. Functional and binding studies with muscarinic M2-subtype selective antagonists.
    Lazareno S, Roberts FF.
    Br J Pharmacol; 1989 Sep 03; 98(1):309-17. PubMed ID: 2804551
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
    Ehlert FJ, Tran LP.
    J Pharmacol Exp Ther; 1990 Dec 03; 255(3):1148-57. PubMed ID: 2262898
    [Abstract] [Full Text] [Related]

  • 14. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE, Ramkumar V, Lai WS.
    J Pharmacol Exp Ther; 1986 Aug 03; 238(2):554-63. PubMed ID: 3755473
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes.
    Liebmann C, Nawrath S, Schnittler M, Schubert H, Jakobs KH.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan 03; 345(1):7-15. PubMed ID: 1538792
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD, Annis SJ, Ehlert FJ, Leslie FM.
    J Pharmacol Exp Ther; 1991 Mar 03; 256(3):1173-81. PubMed ID: 2005579
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.